Latest News:

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

News
Radio Show
- Be on our Show!
- Video Interviews
Technology
Cannabis
Energy
BioTech
Mining
Contact Us
- About Us
- Suggestion Box

Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

cannabislife

CLS Holdings USA, Inc. Announces Second Quarter Fiscal 2021 Results

January 13, 2021January 13, 2021 Stock Day Media 86 Views cannabiscompany, cannabislife, cannabislifesciences, CLSH, clsholdingsinc, fiscalquarter

LAS VEGAS, NV / ACCESSWIRE / January 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH), (CSE:CLSH) (“CLS” or the ‘‘Company”), a

Read more

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal

Copyright © 2021 Stock Day Media. All rights reserved.